NASDAQ
23.06.26 | 21:59
6,550 US-Dollar
+0,46 % +0,030
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Profound Medical Corp. (PROF) Dropped Despite High Potential | 1 | Insider Monkey | ||
| 18.05. | Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High? | 15 | Zacks | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.05. | Profound Medical Corp (2): Profound, Telix form partnership on prostate imaging | 4 | Stockwatch | ||
| 14.05. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Profound Medical Corp.: Profound Medical Annual General and Special Meeting of Shareholders Voting Results | 530 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General... ► Artikel lesen | |
| 07.05. | Profound Medical Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 17.04. | Profound Medical Corp (2): Profound to release Q1 results, host call May 7 | 1 | Stockwatch | ||
| 14.04. | Stocks in Play: Profound Medical Corp. | 1 | Baystreet.ca | ||
| 14.04. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 01.04. | Profound Medical Corp.: Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting | 1 | GlobeNewswire (USA) | ||
| 27.03. | Profound Medical Corp (2): Profound talks up Tulsa procedure milestone in Texas | 3 | Stockwatch | ||
| 27.03. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.03. | Profound Medical Corp.: Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone | 2 | GlobeNewswire (USA) | ||
| 16.03. | Profound Medical: Raymond James bestätigt "Outperform"-Rating nach starken Studiendaten | 2 | Investing.com Deutsch | ||
| 16.03. | Profound Medical stock rating reiterated by Raymond James on trial data | 2 | Investing.com | ||
| 13.03. | Profound Medical Corp.: CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence | 2 | GlobeNewswire (USA) | ||
| 13.03. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Profound Medical Corp (2): Profound to discuss Captain trial results March 13 | 14 | Stockwatch | ||
| 06.03. | Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026 | 6 | Seeking Alpha |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,560 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics to Provide Business Update Call on June 30, 2026 | ||
| ORGANON | 11,710 | -0,97 % | Organon and Henlius launch Prolia and Xgeva biosimilars in Canada | ||
| QUIDELORTHO | 10,485 | -0,19 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,520 | +0,66 % | Nano-X Imaging Ltd: Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems | Advances Nanox's ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. ("Nanox", or the "Company", NASDAQ: NNOX), a leader... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,600 | +1,69 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| NUWELLIS, INC | 0,127 | -1,09 % | Nuwellis, Inc.: Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit | ||
| NYXOAH | 1,438 | +1,84 % | Nyxoah Receives $15 Million from the European Investment Bank | Nyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements the Company's June equity raise, bringing total capital raised to $110 million Mont-Saint-Guibert... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,600 | 0,00 % | Evercore ISI initiates Procept BioRobotics stock with outperform rating | ||
| NEURONETICS | 1,115 | +3,72 % | Neuronetics, Inc. - 8-K, Current Report | ||
| PULSE BIOSCIENCES | 23,000 | +0,88 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| PROGYNY | 26,610 | -0,08 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| OPTIMIZERX | 4,565 | +0,55 % | OptimizeRx Corporation: OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance | - Q1 revenue totals $19.8 million- Q1 net loss and adjusted EBITDA came in at $(0.5) million and $3.3 million, respectively- 2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance... ► Artikel lesen | |
| PAVMED | 3,955 | -4,47 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 7,750 | +2,65 % | Orthofix Medical Inc. - 8-K, Current Report | ||
| OWLET | 5,310 | +0,57 % | Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last? |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,46 % bei einem Aktienkurs von 6,550 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.